Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Anti-PSCA(dCH2)BBz-CAR-T cells |
| Trade Name | |
| Synonyms | anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T lymphocytes |
| Drug Descriptions |
Anti-PSCA(dCH2)BBz-CAR-T cells are T-cells engineered to express a PSCA-targeted chimeric antigen receptor (CAR) containing a TNFRSF9 (4-1BB) signaling domain and truncated CD19, which may induce killing of PSCA-expressing tumor cells and inhibit tumor growth (PMID: 29308300). |
| DrugClasses | PSCA Immune Cell Therapy 3 |
| CAS Registry Number | NA |
| NCIT ID | C157746 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Anti-PSCA(dCH2)BBz-CAR-T cells | Anti-PSCA(dCH2)BBz-CAR-T cells | 0 | 2 |